Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May:479-480:131-45.
doi: 10.1016/j.virol.2015.03.012. Epub 2015 Mar 26.

APOBECs and virus restriction

Affiliations
Review

APOBECs and virus restriction

Reuben S Harris et al. Virology. 2015 May.

Abstract

The APOBEC family of single-stranded DNA cytosine deaminases comprises a formidable arm of the vertebrate innate immune system. Pre-vertebrates express a single APOBEC, whereas some mammals produce as many as 11 enzymes. The APOBEC3 subfamily displays both copy number variation and polymorphisms, consistent with ongoing pathogenic pressures. These enzymes restrict the replication of many DNA-based parasites, such as exogenous viruses and endogenous transposable elements. APOBEC1 and activation-induced cytosine deaminase (AID) have specialized functions in RNA editing and antibody gene diversification, respectively, whereas APOBEC2 and APOBEC4 appear to have different functions. Nevertheless, the APOBEC family protects against both periodic viral zoonoses as well as exogenous and endogenous parasite replication. This review highlights viral pathogens that are restricted by APOBEC enzymes, but manage to escape through unique mechanisms. The sensitivity of viruses that lack counterdefense measures highlights the need to develop APOBEC-enabling small molecules as a new class of anti-viral drugs.

Keywords: APOBEC family; Cytosine deaminases; DNA viruses; Innate immunity; Retroviruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1. APOBEC hallmarks
(A) A schematic of the single-stranded DNA cytosine deamination reaction catalyzed by APOBEC family members. (B) A ribbon model of the A3G catalytic domain showing its globular structure and a blow-up of the zinc-coordinating active site (cysteines are depicted in yellow, histidine in blue, and the catalytic glutamate in red). (C) Schematics of the A3 gene composition of several current mammals depicted above the repertoire of a likely common ancestor and current non-mammalian vertebrates. The color scheme distinguishes phylogenetic subfamilies. See the text for additional details.
Figure 2
Figure 2. Model for HIV-1 restriction by APOBEC3 enzymes and virus protection by Vif
HIV-1 infection of T cells allows expression of Vif, which recruits CBF-β to form an E3 ubiquitin ligase complex that degrades several different A3 proteins (A3D, A3G, A3F, and A3H). In the absence of Vif, these A3 proteins can package into virions. During subsequent infection of susceptible cells, these A3 proteins deaminate viral cDNA cytosines to uracils and directly impede reverse transcription. Viral cDNA uracils template the insertion of genomic strand adenines and result in hallmark G-to-A hypermutations. See the text for details [adapted from (Harris et al., 2012), based upon prior studies].
Figure 3
Figure 3
Model for glyco-Gag protection from restriction by murine A3. The left image depicts glyco-Gag as an oblong blue shape that prevents A3 from accessing reverse transcription complexes. Capsids are primarily composed of the classical Gag (circles not depicted on the left panel). The right panel depicts Gag as a blue oval that causes the capsid to be more loosely formed and susceptible to the A3-mediated block in reverse transcription. Although low levels of G-to-A mutation have been reported, these changes are a minor outcome of A3 activity and are not depicted for clarity. See the text for additional details.

References

    1. Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr Biol. 2006;16:1565–1570. - PubMed
    1. Ai Y, Zhu D, Wang C, Su C, Ma J, Ma J, Wang X. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation. J Virol. 2014;88:12112–12122. - PMC - PubMed
    1. Albin JS, Brown WL, Harris RS. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. Virology. 2014;450–451:49–54. - PMC - PubMed
    1. Alce TM, Popik W. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J Biol Chem. 2004;279:34083–34086. - PubMed
    1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinsk M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van ‘t Veer L, Vincent-Salomon A, Waddell N, Yates LR, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR. Signatures of mutational processes in human cancer. Nature. 2013;500:415–421. - PMC - PubMed

Publication types